Evidence map›Paper›PMID 26993800›Full record

ArticleBrain : a journal of neurology2016

Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.

Katalin Bartus, Jorge Galino, Nicholas D James, Luis R Hernandez-Miranda, John M Dawes, Florence R Fricker, Alistair N Garratt, Stephen B McMahon, Matt S Ramer, Carmen Birchmeier and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway.Frontiers in cell and developmental biology · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Neuregulins in Neurodegenerative Diseases.Frontiers in aging neuroscience · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Katalin BartusThe Wolfson Centre for Age-Related Diseases, Regeneration Group, King's College London, Guy's Campus, London Bridge, London, UK.
Jorge GalinoNuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, UK.
Nicholas D JamesThe Wolfson Centre for Age-Related Diseases, Regeneration Group, King's College London, Guy's Campus, London Bridge, London, UK.
Luis R Hernandez-MirandaMax Delbrück Center for Molecular Medicine, Berlin, Germany.
John M DawesNuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, UK.
Florence R FrickerNuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, UK.
Alistair N GarrattMax Delbrück Center for Molecular Medicine, Berlin, Germany Charité Universitätsmedizin Berlin, Charitéplatz, Berlin, Germany.
Stephen B McMahonThe Wolfson Centre for Age-Related Diseases, Regeneration Group, King's College London, Guy's Campus, London Bridge, London, UK.
Matt S RamerInternational Collaboration on Repair Discoveries, The University of British Columbia, Vancouver, Canada.
Carmen BirchmeierMax Delbrück Center for Molecular Medicine, Berlin, Germany.
David L H BennettNuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, UK elizabeth.bradbury@kcl.ac.uk david.bennett@ndcn.ox.ac.uk.
Elizabeth J BradburyThe Wolfson Centre for Age-Related Diseases, Regeneration Group, King's College London, Guy's Campus, London Bridge, London, UK elizabeth.bradbury@kcl.ac.uk david.bennett@ndcn.ox.ac.uk.
John Radcliffe Hospital · GBKing's College London · GBMax Delbrück Center · DEInternational Collaboration On Repair Discoveries · CA

Funding

Medical Research Council G1002055Wellcome Trust 095698Z/11/Z
6 · The paper itself

Abstract

Following traumatic spinal cord injury, acute demyelination of spinal axons is followed by a period of spontaneous remyelination. However, this endogenous repair response is suboptimal and may account for the persistently compromised function of surviving axons. Spontaneous remyelination is largely mediated by Schwann cells, where demyelinated central axons, particularly in the dorsal columns, become associated with peripheral myelin. The molecular control, functional role and origin of these central remyelinating Schwann cells is currently unknown. The growth factor neuregulin-1 (Nrg1, encoded by NRG1) is a key signalling factor controlling myelination in the peripheral nervous system, via signalling through ErbB tyrosine kinase receptors. Here we examined whether Nrg1 is required for Schwann cell-mediated remyelination of central dorsal column axons and whether Nrg1 ablation influences the degree of spontaneous remyelination and functional recovery following spinal cord injury. In contused adult mice with conditional ablation of Nrg1, we found an absence of Schwann cells within the spinal cord and profound demyelination of dorsal column axons. There was no compensatory increase in oligodendrocyte remyelination. Removal of peripheral input to the spinal cord and proliferation studies demonstrated that the majority of remyelinating Schwann cells originated within the injured spinal cord. We also examined the role of specific Nrg1 isoforms, using mutant mice in which only the immunoglobulin-containing isoforms of Nrg1 (types I and II) were conditionally ablated, leaving the type III Nrg1 intact. We found that the immunoglobulin Nrg1 isoforms were dispensable for Schwann cell-mediated remyelination of central axons after spinal cord injury. When functional effects were examined, both global Nrg1 and immunoglobulin-specific Nrg1 mutants demonstrated reduced spontaneous locomotor recovery compared to injured controls, although global Nrg1 mutants were more impaired in tests requiring co-ordination, balance and proprioception. Furthermore, electrophysiological assessments revealed severely impaired axonal conduction in the dorsal columns of global Nrg1 mutants (where Schwann cell-mediated remyelination is prevented), but not immunoglobulin-specific mutants (where Schwann cell-mediated remyelination remains intact), providing robust evidence that the profound demyelinating phenotype observed in the dorsal columns of Nrg1 mutant mice is related to conduction failure. Our data provide novel mechanistic insight into endogenous regenerative processes after spinal cord injury, demonstrating that Nrg1 signalling regulates central axon remyelination and functional repair and drives the trans-differentiation of central precursor cells into peripheral nervous system-like Schwann cells that remyelinate spinal axons after injury. Manipulation of the Nrg1 system could therefore be exploited to enhance spontaneous repair after spinal cord injury and other central nervous system disorders with a demyelinating pathology.media-1vid110.1093/brain/aww039_video_abstractaww039_video_abstract.

Indexed as

AnimalsAxonsCell ProliferationDemyelinating DiseasesFemaleMiceMice, Mutant StrainsMotor SkillsMyelin SheathNeural ConductionNeuregulin-1Protein IsoformsRatsRecovery of FunctionSchwann CellsSpinal CordNeuregulin-1Protein Isoformsaxon degenerationdemyelinationremyelinationspinal cord injurytransgenic model

Identifiers

PMID26993800
PMCPMC5477508
OpenAlexW2299145287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.